Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,570 | 18,819 | 45,875 | 154,452 | 37,365 |
| Marketable Securities | 253,374 | 249,000 | 233,785 | 171,353 | 225,459 |
| Receivables | 19,947 | 2,966 | 3,680 | 2,885 | 3,607 |
| Inventories | 11,346 | 10,352 | 10,124 | 12,511 | 12,952 |
| Other current assets | 9,814 | 5,214 | 8,782 | 6,092 | 8,817 |
| TOTAL | $350,051 | $286,351 | $302,246 | $347,293 | $288,200 |
| Non-Current Assets | |||||
| PPE Net | 71,336 | 72,532 | 72,158 | 69,267 | 70,368 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 754 | 13,862 | 5,762 | 6,151 | 6,552 |
| TOTAL | $148,591 | $162,895 | $154,421 | $151,919 | $153,421 |
| Total Assets | $498,642 | $449,246 | $456,667 | $499,212 | $441,621 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 125,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,363 | 2,279 | 2,833 | 5,024 | 2,703 |
| Accrued Expenses | 18,416 | 27,074 | 26,687 | 29,515 | 20,374 |
| Other current liabilities | 10,127 | 10,690 | 13,214 | 10,534 | 5,567 |
| TOTAL | $61,246 | $208,098 | $81,077 | $75,444 | $64,047 |
| Non-Current Liabilities | |||||
| Long Term Debt | 241,699 | N/A | 125,000 | 125,000 | 125,000 |
| Deferred Revenues | 21,428 | 20,611 | 22,987 | 24,959 | 24,473 |
| Other Non-Current Liabilities | 125,769 | 131,819 | 138,639 | 138,659 | 135,192 |
| TOTAL | $430,967 | $202,095 | $340,491 | $346,463 | $341,242 |
| Total Liabilities | $492,213 | $410,193 | $421,568 | $421,907 | $405,289 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,067 | 8,901 | 8,829 | 8,773 | 8,763 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -1,867,486 | -1,813,349 | -1,805,146 | -1,752,489 | -1,786,309 |
| Other shareholders' equity | -2,170 | -1,821 | -1,498 | -1,276 | -1,567 |
| TOTAL | $6,429 | $39,053 | $35,099 | $77,305 | $36,332 |
| Total Liabilities And Equity | $498,642 | $449,246 | $456,667 | $499,212 | $441,621 |